メソトレクサート 毒性 の 臨床 症例
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。一人の患者は,毎週ではなく毎日投与されたメトトレキサートによる重度の毒性を経験しました. この一般的な薬の副作用を防ぐには 早期の認識と患者の教育が不可欠です
科学分野
- 薬理学について
- 毒理学について
- 臨床医学
背景
- メソトレクサートは免疫抑制剤と化学療法薬として広く使用されています.
- 潜在的な有害事象のため,注意深くモニタリングすることが不可欠です.
- メソトレクサートによる毒性は,まれですが,重症である可能性があります.
研究 の 目的
- 誤った用量によるメトトレキサート毒性の報告
- 薬の安全性に関する患者教育の重要性を強調する.
- メソトレクサート毒性の臨床表現と管理を強調する.
主な方法
- 病理学的苦情を持つ79歳の男性患者のケーススタディ.
- 患者の投与順序と臨床状況の見直し
- 毒性を確認するための実験室と内視鏡検査
- メソトレクサートとサポートケアを中止する
主要な成果
- 患者は不注意に毎週ではなく毎日10mgのメトトレキサートを取りました.
- 侵食性粘膜炎と胞病変を含む重度のメソトレキサート毒性を発症した.
- 検査結果はパンチトペニアとトランサミニトスでした
- 口腔検査で赤血腫と潰瘍が判明した.
結論
- 薬の誤った投与は重篤な副作用を引き起こす可能性があります.
- 早期発見と介入はメトトレキサート毒性の管理に不可欠です.
- 効果的な患者教育と医療従事者のコミュニケーションは 医薬品の安全性にとって極めて重要です
関連する概念動画
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...